AbbVie Inc. (NYSE:ABBV) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on AbbVie to $269 from $261 with an Overweight rating on the shares ...

AbbVie's major drugs, Skyrizi and Rinvoq, are generating lots of sales. Realty Income's diversified portfolio provides plenty of protection and monthly income. The JEPQ ETF employs a covered-call ...

Memphis filmmaker Craig Brewer's new movie, "Song Sung Blue," opens in theaters in Memphis and across the U.S. and Canada on Christmas Day. Here's some information that might be helpful or interesting ...

So there was no official song of summer. So let’s move beyond the biggest hits and check out the 10 songs we kept coming back to this year. The singer-songwriter who has worked with Miley Cyrus, ...

Listen to 48 tracks that broke new artists, blew apart genres and revived beloved sounds. By Jon Caramanica and Lindsay Zoladz Jon Caramanica On the one hand, living in an environment in which sounds ...

SKYRIZI ® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s ...

Something “Wicked” this way comes not only at the movie theater, but in the music world as well. “Wicked: For Good – The Soundtrack” drops 11 songs nestled in the second volume of the film, with a ...

Cynthia Erivo and Ariana Grande are back as Elphaba and Glinda for “Wicked: For Good,” Jon M. Chu’s latest film which adapts the second act of Stephen Schwartz and Winnie Holzman’s hit musical. Though ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

A new song flooding the internet has been described as the song of the year—but listeners are changing their tune after reports it was made with artificial intelligence. "I Run," a track by new artist ...

AbbVie’s ABBV key top-line drivers are its newer immunology medicines, Rinvoq and Skyrizi. Sales of both these drugs have effectively replaced the company’s flagship drug, Humira, which began facing ...